Product
Durlobactam
1 clinical trial
5 indications
Indication
Acinetobacter baumanniiIndication
Hospital-acquired Bacterial PneumoniaIndication
Ventilator-associated PneumoniaIndication
BacteremiaIndication
Colistin Resistant ABCClinical trial
A Randomized, Active-controlled Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus ComplexStatus: Completed, Estimated PCD: 2021-07-26